Kaken PharmaceutialKAKEN PHARMACEUTIAL CO., LTD.4521東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP
About 97% of Kaken Pharmaceutial's sales come from Medicine, with Real estate making up much of the rest.
Out of every ¥100 of sales, about ¥30 is left as operating profit.
For every ¥100 Kaken Pharmaceutial sells, how much goes where, and how much is kept.
Margin funnel (derived from reported values)Gross margin 56.6% → Operating margin 29.7% → Net margin 21.7%
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.